These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1673654)
21. Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Brunner G; Creutzfeldt W; Harke U; Lamberts R Digestion; 1988; 39(2):80-90. PubMed ID: 3410170 [TBL] [Abstract][Full Text] [Related]
22. Omeprazole in patients with mild or moderate reflux esophagitis induces lower relapse rates than ranitidine during maintenance treatment. Annibale B; Franceschi M; Fusillo M; Beni M; Cesana B; Delle Fave G Hepatogastroenterology; 1998; 45(21):742-51. PubMed ID: 9684126 [TBL] [Abstract][Full Text] [Related]
23. The role of omeprazole in healing and prevention of reflux disease. Klinkenberg-Knol EC Hepatogastroenterology; 1992 Feb; 39 Suppl 1():27-30. PubMed ID: 1577392 [TBL] [Abstract][Full Text] [Related]
25. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927 [TBL] [Abstract][Full Text] [Related]
26. Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor. Robinson M; Campbell DR; Sontag S; Sabesin SM Dig Dis Sci; 1995 Mar; 40(3):590-7. PubMed ID: 7895551 [TBL] [Abstract][Full Text] [Related]
27. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy. Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066 [TBL] [Abstract][Full Text] [Related]
28. Is a proton pump inhibitor necessary for the treatment of lower-grade reflux esophagitis? Soga T; Matsuura M; Kodama Y; Fujita T; Sekimoto I; Nishimura K; Yoshida S; Kutsumi H; Fujimoto S J Gastroenterol; 1999 Aug; 34(4):435-40. PubMed ID: 10452673 [TBL] [Abstract][Full Text] [Related]
29. Randomized comparative study of omeprazole and famotidine in reflux esophagitis. Kawano S; Murata H; Tsuji S; Kubo M; Tatsuta M; Iishi H; Kanda T; Sato T; Yoshihara H; Masuda E; Noguchi M; Kashio S; Ikeda M; Kaneko A J Gastroenterol Hepatol; 2002 Sep; 17(9):955-9. PubMed ID: 12167115 [TBL] [Abstract][Full Text] [Related]
30. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists. Klinkenberg-Knol EC; Jansen JB; Lamers CB; Nelis F; Snel P; Meuwissen SG Scand J Gastroenterol Suppl; 1989; 166():88-93; discussion 94. PubMed ID: 2574911 [TBL] [Abstract][Full Text] [Related]
31. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy. Klinkenberg-Knol EC; Meuwissen SG Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868 [TBL] [Abstract][Full Text] [Related]
32. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Hetzel DJ; Dent J; Reed WD; Narielvala FM; Mackinnon M; McCarthy JH; Mitchell B; Beveridge BR; Laurence BH; Gibson GG Gastroenterology; 1988 Oct; 95(4):903-12. PubMed ID: 3044912 [TBL] [Abstract][Full Text] [Related]
33. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Jansen JB; Klinkenberg-Knol EC; Meuwissen SG; De Bruijne JW; Festen HP; Snel P; Lückers AE; Biemond I; Lamers CB Gastroenterology; 1990 Sep; 99(3):621-8. PubMed ID: 2199288 [TBL] [Abstract][Full Text] [Related]
34. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery. Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587 [TBL] [Abstract][Full Text] [Related]
35. Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty-four-hour intragastric acidity. Kato S; Ebina K; Fujii K; Chiba H; Nakagawa H J Pediatr; 1996 Mar; 128(3):415-21. PubMed ID: 8774516 [TBL] [Abstract][Full Text] [Related]
36. The use of omeprazole for resistant oesophagitis in children. Martin PB; Imong SM; Krischer J; Noblett HR; Sandhu BK Eur J Pediatr Surg; 1996 Aug; 6(4):195-7. PubMed ID: 8877348 [TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Chiba N Can J Gastroenterol; 1997 Sep; 11 Suppl B():66B-73B. PubMed ID: 9347181 [TBL] [Abstract][Full Text] [Related]
38. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease. Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695 [TBL] [Abstract][Full Text] [Related]
39. Omeprazole for severe reflux esophagitis in children. De Giacomo C; Bawa P; Franceschi M; Luinetti O; Fiocca R J Pediatr Gastroenterol Nutr; 1997 May; 24(5):528-32. PubMed ID: 9161946 [TBL] [Abstract][Full Text] [Related]
40. [Long-term maintenance treatment of reflux esophagitis resistant to H2-RA with PPI (lansoprazole)]. Endo M; Sugihara K Nihon Rinsho; 2000 Sep; 58(9):1865-70. PubMed ID: 11004817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]